Blog
ICH releases updated draft guideline for general considerations for clinical studies
The International Council for Harmonization (ICH) released an updated version of its guideline on general considerations for clinical trials, RAPS reports. ICH released the guideline, E8(R1), earlier this May for public consultation on the draft.The...
Meet Pearl IRB at ACRP 2019 in Nashville, TN
Pearl IRB will attend and exhibit at the upcoming Association of Clinical Research Professionals (ACRP) 2019 conference. The event takes place April 12 - 15 in Nashville, Tennessee. Stop by our booth (#549) to meet our team! About ACRP 2019 ACRP 2019 brings the...
Adoption of eConsent: When will it begin?
Rapid development of technology in the medical industry is forcing life science companies and research institutions to review and modify internal procedures to adapt. Electronic informed consent (eConsent), though still highly debated, is a prominent example of a...
Principle Investigators often struggle to follow their own protocol, FDA records reveal
According to recent records published by the U.S. Food and Drug Administration (FDA), the medical industry is experiencing an alarming rise in the number of failures to follow protocol. A report produced by FDA’s Bioresearch...
Reminder: The Common Rule revisions become effective January 21, 2019
Kind of like finishing the Indy 500 on a yellow flag – with the government shut down and no one available to postpone the changes, it appears the new Common Rule revisions will go into effect January 21st. After the 21st, the IRB will ask you to update your study...